Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Neoplasms × gancotamab × Clear all

Phase

Status

Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 67 Capecitabine 52 Cyclophosphamide 49 Paclitaxel 46 Docetaxel 45 Letrozole 39 Fulvestrant 36 Lapatinib 29 Carboplatin 29 Doxorubicin 28 Vinorelbine 27 Bevacizumab 26 Anastrozole 22 exemestane 21 pembrolizumab 20 Tamoxifen 19 Gemcitabine 19 Albumin-Bound Paclitaxel 18 Radiotherapy 17 Taxes 14 Everolimus 14 Epirubicin 13 palbociclib 12 pertuzumab 11 Ado-Trastuzumab Emtansine 11 130-nm albumin-bound paclitaxel 11 eribulin 10 atezolizumab 10 Surveys and Questionnaires 10 Magnetic Resonance Spectroscopy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02213744 2017-01-06

HERMIONE

Merrimack Pharmaceuticals

Phase 2/3 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡